[125I]-(1E,4E)-1-(4-Iodophenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one

ID: ALA1767207

Chembl Id: CHEMBL1767207

PubChem CID: 52937745

Max Phase: Preclinical

Molecular Formula: C18H16INO

Molecular Weight: 389.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1

Standard InChI:  InChI=1S/C18H16INO/c1-20-17-10-4-15(5-11-17)7-13-18(21)12-6-14-2-8-16(19)9-3-14/h2-13,20H,1H3/b12-6+,13-7+/i19-2

Standard InChI Key:  MSFNSFLHZNCRHZ-RPKLKCCOSA-N

Associated Targets(Human)

APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Blood (1764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heart (1016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Spleen (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lung (1108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kidney (1278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stomach (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Intestine (514 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Thyroid (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.24Molecular Weight (Monoisotopic): 389.0277AlogP: 4.63#Rotatable Bonds: 5
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.55CX LogP: 5.23CX LogD: 5.23
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.60Np Likeness Score: -0.28

References

1. Cui M, Ono M, Kimura H, Liu B, Saji H..  (2011)  Synthesis and structure-affinity relationships of novel dibenzylideneacetone derivatives as probes for β-amyloid plaques.,  54  (7): [PMID:21417461] [10.1021/jm101404k]

Source